Target species
Pigs
Indications for use
For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. To reduce loss of daily weight gain and mortality associated with PCV2 infection.
Onset of immunity: 2 weeks after vaccination.
Duration of immunity: 23 weeks after vaccination.
Contraindications
None
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Use of the vaccine in boars has not been evaluated.
Operator Warnings
This veterinary medicinal product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physian
This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse reactions
Transient local reactions mostly consisting of hard non-painful swellings of up to 2 cm diameter were very commonly observed in laboratory studies and field trials. A biphasic pattern of the local reactions, consisting of an increase and decrease followed by another increase and decrease of the size, is commonly observed. In individual pigs the size may increase to 4 cm and redness may be observed. The local reactions disappear completely within approximately 5 weeks after vaccination.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy or lactation
Can be used during pregnancy and lactation
Interactions
Safety and efficacy data are available which demonstrate that this vaccine can be given with Porcilis M Hyo ID ONCE on the same day from 3 weeks of age, either at different sites (e.g. alternate sides of the neck), or at the same site providing that intradermal administration of each vaccine is separated by at least 3 cm.
The product literature of Porcilis M Hyo ID ONCE should be consulted. In case both vaccines are used on the same day the size of the local reactions may increase up to 6 cm in individual pigs, may last 7 weeks and are very commonly accompanied by redness and crusts. In the event that the crust is rubbed off, some small skin damage may be commonly observed. Moreover, a transient increase in body temperature on the day of vaccination of about 0.2 °C is common. In individual pigs this temperature may increase up to 2 °C. The animal’s temperature returns to normal within 1-2 days after the peak temperature is observed.
Safety and efficacy data are available in pigs from 3 weeks of age onwards which demonstrate that this vaccine can be mixed with Porcilis Lawsonia ID (see section 4.9 below). The product literature of Porcilis Lawsonia ID should be consulted before administration. Adverse reactions are as described in section 4.6, except for local injection site reactions where a maximum size of up to 7 cm may occur in individual pigs.
Amounts to be administered and administration route
For intradermal use.
Before using the vaccine allow it to reach room temperature (15℃ – 25℃) and shake well before use.
Avoid multiple broaching.
Safety and efficacy data are available in pigs from 3 weeks of age onwards which demonstrate that this vaccine can be mixed with Porcilis Lawsonia ID (see section 4.9 below). The product literature of Porcilis Lawsonia ID should be consulted before administration. Adverse reactions are as described in section 4.6, except for local injection site reactions where a maximum size of up to 7 cm may occur in individual pigs.
Safety and efficacy of Porcilis PCV ID have been demonstrated using the device IDAL.
Vaccination scheme:
Vaccinate once from an age of 3 weeks onwards and re-vaccination at 23 weeks interval is recommended.
Mixed use with Porcilis Lawsonia ID
Porcilis PCV ID may be used to reconstitute Porcilis Lawsonia lyophilisate shortly before vaccination in pigs from 3 weeks of age onwards as follows:
Porcilis Lawsonia ID lyophilisate | Porcilis PCV ID |
50 doses | 10 ml |
100 doses | 20 ml |
For proper reconstitution and correct administration, use the following procedure:
1. Allow Porcilis PCV ID to reach room temperature and shake well before use.
2. Add approximately 5-10 ml of Porcilis PCV ID to the Porcilis Lawsonia ID lyophilisate and mix briefly.
3. Withdraw the reconstituted concentrate from the vial and transfer it back into the vial with the Porcilis PCV ID. Shake briefly to mix.
4. Use the vaccine suspension within 6 hours of reconstitution. Any vaccine remaining at the end of this time should be discarded.
Dosage:
A single dose (0.2 ml) of Porcilis Lawsonia ID mixed with Porcilis PCV ID is given intradermally in the neck.
Visual appearance after reconstitution: homogenous white to nearly white emulsion after shaking.
Avoid introduction of a contamination by multiple broaching.
Overdose
No data available
Withdrawal period
Zero days